Docosahexaenoic acid (DHA) is an omega‑3 fatty acid that serves as a key structural component of cell membranes, especially in the brain and cardiovascular system. Higher DHA levels generally indicate better incorporation of omega‑3s, which can support heart health, cognitive function, and anti‑inflammatory processes, while lower levels may suggest insufficient dietary intake of marine‑based omega‑3s, potentially contributing to suboptimal cardiovascular or neurological health. Common drivers of DHA status include consumption of fatty fish, algae‑derived supplements, and overall dietary patterns rich in omega‑3 fats; conversely, high intake of omega‑6 fatty acids or certain metabolic conditions can reduce DHA levels. This biomarker is relevant to cardiometabolic health and is measured in laboratory panels.
Lab metric
DHA (omega-3)
Docosahexaenoic acid (DHA) is an omega‑3 fatty acid that serves as a key structural component of cell membranes, especially in the brain and cardiovascular system. Higher DHA levels generally indicate better incorporation of omega‑3s, which can support heart health, cognitive function, and anti‑inflammatory processes, while lower levels may suggest insufficient dietary intake of marine‑based omega‑3s, potentially contributing to suboptimal cardiovascular or neurological health. Common drivers of DHA status include consumption of fatty fish, algae‑derived supplements, and overall dietary patterns rich in omega‑3 fats; conversely, high intake of omega‑6 fatty acids or certain metabolic conditions can reduce DHA levels. This biomarker is relevant to cardiometabolic health and is measured in laboratory panels.


